Participants
Ninety healthy participants (age range 18-27 years) were recruited for the randomized placebo-controlled between-subject pharmacological fMRI study which encompassed a single-dose p.o. administration of 50mg LT or placebo (PLC) and subsequent administration of a social incentive delay fMRI paradigm (SID) with a demonstrated sensitivity to capture pharmacological modulations (5). N = 87 subjects (N=43, 26 males, LT; N=44, 24 males, PLC; Table 1 ) were included in the final analyses (exclusion see supplementary method ).